Barreca ML - Search Results

1

Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking.

De Luca L, Pedretti A, Vistoli G, Barreca ML, Villa L, Monforte P, Chimirri A. De Luca L, et al. Among authors: barreca ml. Biochem Biophys Res Commun. 2003 Oct 31;310(4):1083-8. doi: 10.1016/j.bbrc.2003.09.120. Biochem Biophys Res Commun. 2003. PMID: 14559226

2

Substituent effects on the enantioselective retention of anti-HIV 5-aryl-delta 2-1,2,4-oxadiazolines on R,R-DACH-DNB chiral stationary phase.

Altomare C, Cellamare S, Carotti A, Barreca ML, Chimirri A, Monforte AM, Gasparrini F, Villani C, Cirilli M, Mazza F. Altomare C, et al. Among authors: barreca ml. Chirality. 1996;8(8):556-66. doi: 10.1002/(SICI)1520-636X(1996)8:8<556::AID-CHIR4>3.0.CO;2-7. Chirality. 1996. PMID: 9025255

3

Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs).

Barreca ML, Carotti A, Carrieri A, Chimirri A, Monforte AM, Calace MP, Rao A. Barreca ML, et al. Bioorg Med Chem. 1999 Nov;7(11):2283-92. doi: 10.1016/s0968-0896(99)00181-9. Bioorg Med Chem. 1999. PMID: 10632038

4

Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents.

Barreca ML, Chimirri A, De Luca L, Monforte AM, Monforte P, Rao A, Zappalà M, Balzarini J, De Clercq E, Pannecouque C, Witvrouw M. Barreca ML, et al. Bioorg Med Chem Lett. 2001 Jul 9;11(13):1793-6. doi: 10.1016/s0960-894x(01)00304-3. Bioorg Med Chem Lett. 2001. PMID: 11425562

5

Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.

Barreca ML, Balzarini J, Chimirri A, De Clercq E, De Luca L, Höltje HD, Höltje M, Monforte AM, Monforte P, Pannecouque C, Rao A, Zappalà M. Barreca ML, et al. J Med Chem. 2002 Nov 21;45(24):5410-3. doi: 10.1021/jm020977+. J Med Chem. 2002. PMID: 12431069

6

Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist.

Gitto R, Barreca ML, De Luca L, De Sarro G, Ferreri G, Quartarone S, Russo E, Constanti A, Chimirri A. Gitto R, et al. Among authors: barreca ml. J Med Chem. 2003 Jan 2;46(1):197-200. doi: 10.1021/jm0210008. J Med Chem. 2003. PMID: 12502375

7

Binding modes of noncompetitive AMPA antagonists: a computational approach.

De Luca L, Macchiarulo A, Costantino G, Barreca ML, Gitto R, Chimirri A, Pellicciari R. De Luca L, et al. Among authors: barreca ml. Farmaco. 2003 Feb;58(2):107-13. doi: 10.1016/s0014-827x(02)00027-7. Farmaco. 2003. PMID: 12581776

8

Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: mechanism for inhibition and drug resistance.

Barreca ML, Lee KW, Chimirri A, Briggs JM. Barreca ML, et al. Biophys J. 2003 Mar;84(3):1450-63. doi: 10.1016/S0006-3495(03)74958-3. Biophys J. 2003. PMID: 12609852 Free PMC article.

9

Anti-HIV agents: design and discovery of new potent RT inhibitors.

Barreca ML, Chimirri A, De Clercq E, De Luca L, Monforte AM, Monforte P, Rao A, Zappalà M. Barreca ML, et al. Farmaco. 2003 Mar;58(3):259-63. doi: 10.1016/S0014-827X(03)00024-7. Farmaco. 2003. PMID: 12620421 Review.

10

Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists.

Barreca ML, Gitto R, Quartarone S, De Luca L, De Sarro G, Chimirri A. Barreca ML, et al. J Chem Inf Comput Sci. 2003 Mar-Apr;43(2):651-5. doi: 10.1021/ci025625q. J Chem Inf Comput Sci. 2003. PMID: 12653534

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters